Ex vivo spontaneous proliferation of PBMCs from ATLL and HAM/TSP was inhibited using a selective inhibitor of Jak3, which blocks signaling mediated by IL2, IL9 and IL15 [108]. Here, IL9 is linked to adult T-cell leukemia/lymphoma.